FDA Pediatric/Counterterrorism Office Will Announce Division Directors In Fall
Executive Summary
FDA's Office of Counterterrorism and Pediatric Drug Development (OCTAP) is expected to announce directors for its separate counterterrorism and pediatric drug divisions in the fall
You may also be interested in...
FDA Pediatric Drug Division Director Will Be GSK’s Shirley Murphy
Former GlaxoSmithKline NeuroHealth Specialty Division VP Shirley Murphy, MD, will become the first director of FDA's Division of Pediatric Drug Development effective Sept. 9
FDA Pediatric Drug Division Director Will Be GSK’s Shirley Murphy
Former GlaxoSmithKline NeuroHealth Specialty Division VP Shirley Murphy, MD, will become the first director of FDA's Division of Pediatric Drug Development effective Sept. 9
FDA ODE II Directorship Open; Kweder Tapped As Office Of New Drugs Deputy
FDA is looking to fill the Office of Drug Evaluation II director position following the appointment of Sandra Kweder, MD, to the Office of New Drugs as deputy director